DTL
APRE icon

Dynamic Technology Lab’s Aprea Therapeutics APRE Stock Holding History

Dynamic Technology Lab’s Portfolio APRE Stock Details APRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-759
Closed -$44K – 1088
2021
Q4 		$44K Buy
+759
New +$67K ﹤0.01% 1065

Other funds holding APRE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Dynamic Technology Lab's APRE Position: Q1 2022 in Review

Dynamic Technology Lab sold out of Aprea Therapeutics (APRE) in Q1 2022, closing a stake of 759 shares — an estimated $44K sold.

Dynamic Technology Lab first reported a position in APRE in Q4 2021 and held it in 1 quarter. The position peaked at $44K in Q4 2021. 40 funds tracked by Wall St. Rank hold APRE as of Q1 2022.

  • Dynamic Technology Lab reported no remaining Aprea Therapeutics position as of Q1 2022 after selling out during the quarter.
  • Dynamic Technology Lab sold 759 Aprea Therapeutics shares in Q1 2022, an estimated $44K.
  • Dynamic Technology Lab first reported a position in Aprea Therapeutics in Q4 2021 and held it in 1 quarter.
  • Dynamic Technology Lab's Aprea Therapeutics position peaked at $44K in Q4 2021.
  • 40 funds tracked by Wall St. Rank held Aprea Therapeutics as of Q1 2022.

Based on Dynamic Technology Lab's 13F filing for Q1 2022, filed 16 May 2022.